Literature DB >> 11891043

Human homologue of a gene mutated in the slow Wallerian degeneration (C57BL/Wld(s)) mouse.

F Shama Fernando1, Laura Conforti, Sabrina Tosi, A David Smith, Michael P Coleman.   

Abstract

The slow Wallerian degeneration mouse (C57BL/Wld(s)) is a mutant strain of mouse, with the unique phenotype of prolonged survival of the distal axon following axotomy. The causative mutation is an 85 kb tandem triplication on distal mouse chromosome 4. The dominant slow Wallerian degeneration phenotype is conferred by a hybrid gene within the triplication, comprising a gene of previously unknown function, D4Cole1e, and the 5' end of ubiquitination factor E4B (Ube4b). It encodes an in-frame fusion protein consisting of the N-terminal 70 amino acids of Ube4b and 303 amino acids derived from the D4Cole1e gene. We have identified the human homologue of D4Cole1e, and mapped it to chromosome 1p36.2. Additional fluorescence in situ hybridisation signals indicate the presence of several homologous human sequences. Northern blot analysis shows two transcripts, widely expressed at varying levels in different human tissues. The human cDNA, which encodes a protein of 279 amino acids, has 80% nucleotide identity with the mouse cDNA. The derived human and mouse protein sequences share 78% amino acid identity and 82% amino acid similarity. The human cDNA and protein sequences are identical to the human nicotinamide mononucleotide adenylyltransferase (NMNAT). We have also determined the intron/exon structure of the gene, which will facilitate the screening of these exons for mutations in human neurodegenerative disorders.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11891043     DOI: 10.1016/s0378-1119(02)00394-3

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  7 in total

Review 1.  Location, Location, Location: Compartmentalization of NAD+ Synthesis and Functions in Mammalian Cells.

Authors:  Xiaolu A Cambronne; W Lee Kraus
Journal:  Trends Biochem Sci       Date:  2020-06-25       Impact factor: 13.807

Review 2.  NAD(+)/NADH and skeletal muscle mitochondrial adaptations to exercise.

Authors:  Amanda T White; Simon Schenk
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-03-20       Impact factor: 4.310

3.  Homology modeling and deletion mutants of human nicotinamide mononucleotide adenylyltransferase isozyme 2: new insights on structure and function relationship.

Authors:  Lucia Brunetti; Michele Di Stefano; Silverio Ruggieri; Flavio Cimadamore; Giulio Magni
Journal:  Protein Sci       Date:  2010-12       Impact factor: 6.725

4.  Characterization of human brain nicotinamide 5'-mononucleotide adenylyltransferase-2 and expression in human pancreas.

Authors:  Joel A Yalowitz; Suhong Xiao; Mangatt P Biju; Aśok C Antony; Oscar W Cummings; Mark A Deeg; Hiremagalur N Jayaram
Journal:  Biochem J       Date:  2004-01-15       Impact factor: 3.857

Review 5.  The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways.

Authors:  Riekelt H Houtkooper; Carles Cantó; Ronald J Wanders; Johan Auwerx
Journal:  Endocr Rev       Date:  2009-12-09       Impact factor: 19.871

Review 6.  NAD and axon degeneration: from the Wlds gene to neurochemistry.

Authors:  Jing Wang; Zhigang He
Journal:  Cell Adh Migr       Date:  2009-01-25       Impact factor: 3.405

7.  Protective role of Wallerian degeneration slow (Wld(s)) gene against retinal ganglion cell body damage in a Wallerian degeneration model.

Authors:  Cheng-Hu Wang; Bo Wang; Ri-LE Wendu; Hui-E Bi; Guo-Fan Cao; Chao Ji; Qin Jiang; Jin Yao
Journal:  Exp Ther Med       Date:  2012-11-30       Impact factor: 2.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.